Related Experiment Video
Updated: Jun 30, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Cycloartane glycosides from Sutherlandia frutescens
Xiang Fu1, Xing-Cong Li, Troy J Smillie
1Department of Pharmacognosy, National Center for Natural Products Research, School of Pharmacy, The University of Mississippi, University, Mississippi 38677, USA.
Four novel cycloartane glycosides were isolated from Sutherlandia frutescens. These compounds, including a unique secocycloartane and cycloartanes with a C-1 ketone, expand our understanding of natural product chemistry.
Area of Science:
- Natural Product Chemistry
- Phytochemistry
- Medicinal Chemistry
Background:
- Sutherlandia frutescens is a South African folk medicine with a history of traditional use.
- Cycloartane glycosides are a class of natural products with diverse biological activities.
- Understanding the chemical constituents of medicinal plants is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize new cycloartane glycosides from Sutherlandia frutescens.
- To elucidate the structures of these novel compounds using spectroscopic and crystallographic methods.
- To investigate the structural novelty and potential biosynthetic implications of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via Nuclear Magnetic Resonance (NMR) spectroscopy and Mass Spectrometry (MS).
- Confirmation of structure through X-ray crystallography.
Main Results:
- Four new cycloartane glycosides, sutherlandiosides A-D (1-4), were successfully isolated.
- Compound 1, a secocycloartane glycoside, features a novel 7,10-oxygen bridge.
- Compounds 2-4 are the first naturally occurring cycloartanes identified with a C-1 ketone functionality.
- The C-1 ketone in compound 2 may play a role in the ring opening of the cyclopropane system.
Conclusions:
- The study identified four unique cycloartane glycosides from Sutherlandia frutescens, expanding the known structural diversity of this compound class.
- The discovery of a novel secocycloartane skeleton and cycloartanes with a C-1 ketone functionality provides new insights into cycloartane biosynthesis.
- These findings contribute to the phytochemical understanding of Sutherlandia frutescens and may inform future research into its medicinal properties.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Cycloalkanes
The IUPAC nomenclature of cycloalkanes follows similar rules that apply to...
Drugs that Stabilize Microtubules
Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation
